NorthX Biologics welcomes new CEO
NorthX Biologics AB has appointed Dr Janet Hoogstraate as its new Chief Executive Officer, effective at the end of August.
ADVERTISEMENT
ADVERTISEMENT
This author has not written his bio yet.
But we are proud to say that Maren Kühr contributed 189 entries already.
NorthX Biologics AB has appointed Dr Janet Hoogstraate as its new Chief Executive Officer, effective at the end of August.
Basel- and Heidelberg-based CDMO Celonic Group has appointed Dr Samanta Cimitan as Chief Executive Officer (CEO).
ViroCell Biologics, based in London, Dublin and New York, has appointed Brian Collins as Chief Financials Officer.
Toulouse-based Flash Therapeutics has appointed Jerome Bedier as its new President.
The Innovative Health Initiative (IHI) Governing Board has appointed Niklas Blomberg to be the next Executive Director of the organisation. Dr Blomberg has extensive experience of working in Europes life science sector, and is currently Director of ELIXIR, the European life sciences data infrastructure. He will take up his duties at IHI in early 2024.
UK-based CRO Cresset has expanded its senior leadership team with the appointment of Nick Foster as Vice President of their Discovery CRO business.
The appointment of Kate Woolland as new Chief Operating Officer of London-based Closed Loop Medicine Ltd supports delivery of the Companys product and partnership programs.
Inflation has rebounded with a vengeance from its pandemic-induced recession lows. The US headline inflation rate surged to levels not seen since Ronald Reagan’s presidency, while the Eurozone’s Harmonised Index of Consumer Price (HICP) rose to the highest level in its entire 30-year lifespan.
Leiden-based Amarna Therapeutics announces the appointment of Dr Henk Streefkerk as the company’s new Chief Executive Officer and Medical Director. Streefkerk has already been Amarna’s Medical Director since mid-2022.